rs121909485

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong

The NM_005726.6(TSFM):​c.934C>T​(p.Arg312Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000314 in 1,466,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R312L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

TSFM
NM_005726.6 missense

Scores

11
7
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 0.612
Variant links:
Genes affected
TSFM (HGNC:12367): (Ts translation elongation factor, mitochondrial) This gene encodes a mitochondrial translation elongation factor. The encoded protein is an enzyme that catalyzes the exchange of guanine nucleotides on the translation elongation factor Tu during the elongation step of mitchondrial protein translation. Mutations in this gene are associated with combined oxidative phosphorylation deficiency-3 syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.964
PP5
Variant 12-57796539-C-T is Pathogenic according to our data. Variant chr12-57796539-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 5379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TSFMNM_005726.6 linkuse as main transcriptc.934C>T p.Arg312Trp missense_variant 6/6 ENST00000652027.2
TSFMNM_001172696.2 linkuse as main transcriptc.997C>T p.Arg333Trp missense_variant 7/7
TSFMNM_001172695.2 linkuse as main transcriptc.*342C>T 3_prime_UTR_variant 5/5
TSFMNM_001172697.2 linkuse as main transcriptc.571+3466C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TSFMENST00000652027.2 linkuse as main transcriptc.934C>T p.Arg312Trp missense_variant 6/6 NM_005726.6 P1P43897-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151978
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000312
AC:
41
AN:
1314842
Hom.:
0
Cov.:
31
AF XY:
0.0000375
AC XY:
24
AN XY:
639898
show subpopulations
Gnomad4 AFR exome
AF:
0.000101
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000328
Gnomad4 OTH exome
AF:
0.0000371
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151978
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74198
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00000882
Hom.:
0
Bravo
AF:
0.0000340
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000253
AC:
3

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Pathogenic:4
Pathogenic, no assertion criteria providedliterature onlyOMIMApr 01, 2012- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Apr 09, 2021- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsDec 07, 2023- -
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteJul 16, 2023Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with combined oxidative phosphorylation deficiency 3 (COXPD3) (MIM#610505). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (5 heterozygotes, 0 homozygotes). (SP) 0309 - Alternative amino acid changes at the same position have been observed in gnomAD (v2) (3 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The variant has previously been reported as pathogenic in a homozygous state in more than five patients with COXPD3 (ClinVar, HGMD, PMID: 17033963, PMID: 31267352). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Functional studies in patient cells demonstrated decreased protein levels as well as a reduction in assembled mitochondrial complexes I, IV and V (PMID: 17033963). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsMar 14, 2022The c.997C>T (p.R333W) alteration is located in coding exon 7 of the TSFM gene. This alteration results from a C to T substitution at nucleotide position 997, causing the arginine (R) at amino acid position 333 to be replaced by a tryptophan (W). Based on data from the Genome Aggregation Database (gnomAD), the c.997C>T alteration was observed in 0.0015% (3/201,630) total alleles studied, with a frequency of 0.004% (1/23,492) in the African subpopulation. This alteration was reported homozygous in multiple unrelated patients with severe combined oxidative phosphorylation deficiency, born to consanguineous parents (Smeitink, 2006; Smits, 2011; Calvo, 2012; Shamseldin, 2012; Vedrenne, 2012). This amino acid position is highly conserved in available vertebrate species. The p.R333 amino acid is located in an evolutionarily conserved site in a subdomain of EFTs that interacts with EFTu. Molecular modeling predicted that the mutation disrupts local subdomain structure and the dimerization interface (Smeitink, 2006). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 21, 2024This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 333 of the TSFM protein (p.Arg333Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with mitochondrial disorders (PMID: 17033963, 21741925, 22277967). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg312Trp. ClinVar contains an entry for this variant (Variation ID: 5379). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSFM protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects TSFM function (PMID: 20435138). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.67
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.67
D;.
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.96
D;D
MetaSVM
Pathogenic
0.81
D
MutationAssessor
Pathogenic
4.2
H;.
MutationTaster
Benign
1.0
A;A;A;A;A;A;A
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-7.0
D;D
REVEL
Pathogenic
0.90
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.88
MVP
0.93
MPC
0.32
ClinPred
1.0
D
GERP RS
2.4
Varity_R
0.82
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121909485; hg19: chr12-58190322; API